Evidence map›Paper›PMID 18368064›Full record

ArticleGenes and immunity2008

IL23R: a susceptibility locus for celiac disease and multiple sclerosis?

C Núñez, B Dema, M C Cénit, I Polanco, C Maluenda, R Arroyo, V de las Heras, M Bartolomé, E G de la Concha, E Urcelay and 1 more

Abstract read
PubMed Publisher
In one paragraph

Article in Genes and immunity, 2008. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 33 papers.

0numbers the graph read from it
0cells of the map it votes in
33citing papers in PubMed
4.8field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

33 citing papers in PubMed, 84 citations in OpenAlex.

  1. Trial
  2. Article
  3. Review
  4. Article
  5. Review
  6. IL-23R gene polymorphisms in rheumatoid arthritis.Rheumatology international · 2022
    Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. The obesity-related pathology and Th17 cells.Cellular and molecular life sciences : CMLS · 2017
    Review
  15. Article
  16. Review
  17. Article
  18. Article
  19. Review
  20. Lack of association between IL-23R gene polymorphisms and systemic lupus erythematosus in a Chinese population.Inflammation research : official journal of the European Histamine Research Society ... [et al.] · 2013
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 2 institutions in 1 country.

C NúñezServicio de Inmunología Clínica, Hospital Clínico San Carlos, Madrid, Spain. conchita.npardo@gmail.com
B Dema
M C Cénit
I Polanco
C Maluenda
R Arroyo
V de las Heras
M Bartolomé
E G de la Concha
E Urcelay
A Martínez
Hospital Clínico San Carlos · ESHospital Universitario La Paz · ES

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Recent studies have shown association of the IL23R gene with inflammatory bowel disease, psoriasis and ankylosing spondylitis. We aimed at studying the involvement of IL23R in celiac disease (CD) and multiple sclerosis (MS). We performed a case-control study including 598 patients with CD, 414 with MS and 546 healthy controls, all of them white Spaniards. All samples were genotyped for two single nucleotide polymorphisms: rs7517847 and rs11209026 (Arg381Gln). Statistical analyses were performed using chi(2-)tests or the Fisher's exact test. The minor allele (Gln) of the coding variant Arg381Gln was significantly increased in CD and MS patients when compared to controls (8% in CD vs 6% in controls, P=0.02; 9% in MS, P=0.006). In MS, a stronger effect was observed in patients showing primary-progressive disease (16%, P=0.004). Moreover, heterozygotes for rs7517847 were significantly increased in this group of MS patients (81% in MS vs 48% in controls, P=0.0002). In conclusion, contrary to what has been described previously, the less frequent allele of the functional polymorphism Arg381Gln (rs11209026) seems to be increasing susceptibility to CD and MS, although in this last group of patients a stronger effect is observed in patients affected of a primary-progressive form.

Indexed as

Genetic Predisposition to DiseaseAllelesCase-Control StudiesCeliac DiseaseChi-Square DistributionGene FrequencyGenetic VariationHaplotypesHeterozygoteHumansMultiple SclerosisPolymorphism, Single NucleotideReceptors, InterleukinIL23R protein, humanReceptors, Interleukin

Identifiers

PMID18368064
OpenAlexW2059763554

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.